| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use pravastatin sodium tablets safely and effectively. See full prescribing information for pravastatin sodium tablets. Pravastatin Sodium Tablets USP, for oral use Initial U.S. Approval: 1991 | 2 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE delayed-release capsules USP, for oral use INITIAL U.S. APPROVAL: 1989 | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 1989 | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 1989 | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP INITIAL U.S. APPROVAL: 1989 | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use Oxcarbazepine Tablets safely and effectively. See full prescribing information for Oxcarbazepine Tablets. Oxcarbazepine Tablets Initial U.S. Approval: 2000 | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use omeprazole safely and effectively. See full prescribing information for omeprazole. OMEPRAZOLE DELAYED-RELEASE CAPSULES, USP Initial U.S. Approval: 1989 | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use Omeprazole Delayed-Release Capsules safely and effectively. See full prescribing information for Omeprazole Delayed-Release Capsules. Initial U.S. Approval: 01/21/2009 | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Pravastatin Sodium Tablets | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval: | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use. See full prescribing information for. Initial U.S. Approval: | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | These highlights do not include all the information needed to use MICARDIS safely and effectively. See full prescribing information for MICARDIS. MICARDIS ® (telmisartan) Tablets Initial U.S. Approval: 1998 | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Micardis ® HCT (telmisartan and hydrochlorothiazide) Tablets, 40 mg/12.5 mg 80 mg/12.5 mg and 80 mg/25 mg | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Pravastatin Sodium Tablets | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Omeprazole Delayed-Release Capsules These highlights do not include all the information needed to use See full prescribing information for use INITIAL U.S. APPROVAL: 2007 | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Omeprazole 20 mg | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Oxcarbazepine Tablets | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Pravastatin Sodium Tablets | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | Pravastatin Sodium Tablets | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 3379 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 430 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRANDIN (REPAGLINIDE) TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 429 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED] | 15 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [ACTAVIS PHARMA, INC.] | 12 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [QUALITEST PHARMACEUTICALS] | 12 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED] | 11 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 11 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | MAGNEVIST (GADOPENTETATE DIMEGLUMINE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.] | 10 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | MAGNEVIST (GADOPENTETATE DIMEGLUMINE) INJECTION [BAYER HEALTHCARE PHARMACEUTICALS INC.] | 8 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OXCARBAZEPINE TABLET, FILM COATED [GLENMARK PHARMACEUTICALS INC., USA] | 8 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [AMERICAN HEALTH PACKAGING] | 7 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRANDIMET (REPAGLINIDE AND METFORMIN HYDROCHLORIDE) TABLET [NOVO NORDISK] | 7 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 6 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | REPAGLINIDE TABLET [MYLAN PHARMACEUTICALS INC.] | 6 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [MYLAN PHARMACEUTICALS INC.] | 6 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [SANDOZ INC] | 6 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | DESLORATADINE TABLET, FILM COATED [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN SODIUM TABLET [GLENMARK PHARMACEUTICALS INC., USA] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | RAMIPRIL CAPSULE [LUPIN PHARMACEUTICALS, INC.] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | REPAGLINIDE TABLET [PADDOCK LABORATORIES, LLC] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN AND HYDROCHLOROTHIAZIDE 40 MG/12.5 MG (TELMISARTAN AND HYDROCHLOROTHIAZIDE) TABLET TELMISARTAN AND HYDROCHLOROTHIAZIDE 80 MG/12.5 MG (TELMISARTAN AND HYDROCHLOROTHIAZIDE) TABLET TELMISARTAN AND HYDROCHLOROTHIAZIDE 80 MG/25 MG (TELMISARTAN AND HYDROCHLOROTHIAZIDE) TABLET [QUALITEST PHARMACEUTICALS] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN AND HYDROCHLOROTHIAZIDE TABLET [MYLAN PHARMACEUTICALS INC.] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [TORRENT PHARMACEUTICALS LIMITED] | 5 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRANDIN (REPAGLINIDE) TABLET [CARDINAL HEALTH] | 4 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | REPAGLINIDE TABLET [MYLAN INSTITUTIONAL INC.] | 4 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | BERKLEY AND JENSEN LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [BJWC] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | EQUALINE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [SUPERVALU INC] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | GADOPENTETATE DIMEGLUMINE INJECTION [ALVOGEN, INC] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [CVS PHARMACY] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [KROGER COMPANY] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK] | 3 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [CARDINAL HEALTH] | 3 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [CLINICAL SOLUTIONS WHOLESALE] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [LEGACY PHARMACEUTICAL PACKAGING] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN SODIUM TABLET [CARDINAL HEALTH] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN SODIUM TABLET [DR.REDDY'S LABORATORIES LIMITED] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | RAMIPRIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | RAMIPRIL CAPSULE [PROFICIENT RX LP] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | REPAGLINIDE TABLET [SANDOZ INC] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | REPAGLINIDE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN AND AMLODIPINE TABLET [MYLAN PHARMACEUTICALS INC.] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN AND AMLODIPINE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN AND HYDROCHLORTHIAZIDE TABLET [TORRENT PHARMACEUTICALS LIMITED] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [GLENMARK PHARMACEUTICALS INC., USA] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | TELMISARTAN TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | UP AND UP LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [TARGET CORPORATION] | 3 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | CAREONE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AMERICAN SALES COMPANY] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | DG HEALTH LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [DOLGENCORP, LLC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [CAMBER PHARMACEUTICALS, INC.] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | GADOPENTETATE DIMEGLUMINE INJECTION [ALVOGEN, INC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | GOOD NEIGHBOR PHARMACY LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [AMERISOURCE BERGEN] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | GOOD SENSE LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [L. PERRIGO COMPANY] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | HEALTH MART LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [MCKESSON] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | HEALTHY ACCENTS LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [DZA BRANDS LLC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | KIRKLAND SIGNATURE LANSOPRAZOLE DELAYED RELEASE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [COSTCO WHOLESALE COMPANY] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [H E B] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [HYVEE INC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [MEIJER DISTRIBUTION INC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PERRIGO NEW YORK INC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PUBLIX SUPER MARKETS INC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [RITE AID CORPORATION] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [WESTERN FAMILY FOODS INC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LEADER LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [CARDINAL HEALTH] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | METACAM (MELOXICAM) INJECTION, SOLUTION [BOEHRINGER INGELHEIM VETMEDICA, INC.] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMECLAMOX-PAK (OMEPRAZOLE, CLARITHROMYCIN, AMOXICILLIN) KIT [PERNIX THERAPEUTICS, LLC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE [UNIT DOSE SERVICES] | 2 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [PREFERRED PHARMACEUTICALS, INC.] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN SODIUM TABLET [CARDINAL HEALTH] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | RAMIPRIL CAPSULE [PD-RX PHARMACEUTICALS, INC.] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | REPAGLINIDE TABLET [AUROBINDO PHARMA LIMITED] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | SUNMARK LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [MCKESSON] | 2 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | WELL AT WALGREENS LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [WALGREEN COMPANY] | 2 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | ELOXIJECT (MELOXICAM) SOLUTION [BUTLER ANIMAL HEALTH SUPPLY, LLC D/B/A HENRY SCHEIN ANIMAL HEALTH] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | EQUATE LANSOPRAZOLE DELAYED RELEASE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [WAL-MART STORES INC] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | EXCHANGE SELECT LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [ARMY & AIR FORCE EXCHANGE SERVICE] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | HARRIS TEETER ACID REDUCER (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [HARRIS TEETER, LLC] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SHOPKO STORES OPERATING CO., LLC] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | LOXICOM (MELOXICAM) SOLUTION [NORBROOK LABORATORIES LIMITED] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | MELOXICAM INJECTION, SOLUTION [BIMEDA INC] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | MELOXICAM INJECTION, SOLUTION [PUTNEY, INC.] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | MEMBERS MARK LANSOPRAZOLE (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE [SAM'S WEST INC] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | NEOGEN DERMALOGY REAL FRESH FOAM CEREAL (NIACINAMIDE) GEL [OUTIN FUTURES CORP.] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | NEOGEN DERMALOGY REAL FRESH FOAM CRANBERRY (NIACINAMIDE) GEL [OUTIN FUTURES CORP.] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | NEOGEN DERMALOGY REAL FRESH FOAM GREEN TEA (NIACINAMIDE) GEL [OUTIN FUTURES CORP.] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [LEGACY PHARMACEUTICAL PACKAGING] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OMEPRAZOLE CAPSULE, DELAYED RELEASE [REMEDYREPACK INC. ] | 1 | |
| meglumine | INACTIVE INGREDIENT | 6HG8UB2MUY | OSTILOX (MELOXICAM) SOLUTION [MWI/VETONE] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | OXCARBAZEPINE TABLET, FILM COATED [MEDSOURCE PHARMACEUTICALS] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN (PRAVASTATIN SODIUM) TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN SODIUM TABLET [MAJOR PHARMACEUTICALS] | 1 | |
| MEGLUMINE | INACTIVE INGREDIENT | 6HG8UB2MUY | PRAVASTATIN SODIUM TABLET [PD-RX PHARMACEUTICALS, INC.] | 1 | |